Pulmatrix, Inc. (PULM) Insider Trading Activity

NASDAQ$1.39+0.06 (4.51%)
Market Cap
$4.86M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
729 of 849
Rank in Industry
419 of 491

PULM Insider Trading Activity

PULM Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
–
Sells
$0
0
–

Related Transactions

About Pulmatrix, Inc.

Pulmatrix, Inc. (PULM) is a clinical-stage biotechnology firm focused on creating and advancing inhaled treatments. The company's primary goal is to address significant unmet medical needs in respiratory and other diseases within the United States. Central to their approach is the innovative iSPERSE (inhaled small particles easily respirable and emitted) technology. This proprietary platform allows for the precise delivery of both small and large molecule therapeutics directly into the lungs, achieving either localized effects or systemic …

Insider Activity of Pulmatrix, Inc.

Over the last 12 months, insiders at Pulmatrix, Inc. have bought $0 and sold $0 worth of Pulmatrix, Inc. stock.

On average, over the past 5 years, insiders at Pulmatrix, Inc. have bought $0 and sold $0 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 1,150,000 shares for transaction amount of $224,608 was made by MCGUIRE TERRANCE () on 2018‑04‑03.

List of Insider Buy and Sell Transactions, Pulmatrix, Inc.

2018-04-03PurchaseMCGUIRE TERRANCE
1.15M
0.9862%
$0.20
$224,608
-22.17%
2018-04-03PurchaseGILLIS STEVENdirector
1.15M
3.2822%
$0.65
$747,500
-22.17%
2018-04-03PurchaseIwicki Mark Tdirector
307,000
0.8762%
$0.65
$199,550
-22.17%
2018-04-03PurchaseSherman Matthew Ldirector
20,000
0.0571%
$0.65
$13,000
-22.17%
2015-06-17SaleOculus Innovative Sciences, Inc.10 percent owner
922,500
3.7852%
$2.75
$2.54M
-66.53%
2015-06-16SaleOculus Innovative Sciences, Inc.10 percent owner
727,500
3.023%
$2.75
$2M
-66.10%
2015-06-16PurchaseGILLIS STEVENdirector
72,750
0.7558%
$6.88
$500,156
-66.10%
2015-06-16PurchaseROCKLAGE SCOTT Mdirector
38,805
0.4031%
$6.88
$266,784
-66.10%
2015-06-16PurchaseMaki Daviddirector
36,375
0.3779%
$6.88
$250,078
-66.10%
2015-06-15PurchaseMCGUIRE TERRANCE
74,036
0.7174%
$6.88
$508,998
-68.30%
2015-03-23SaleOculus Innovative Sciences, Inc.10 percent owner
350,000
0.2347%
$2.75
$962,500
-51.06%
Total: 11

Insider Historical Profitability

<0.0001%
MCGUIRE TERRANCE
3468190
94.9595%
$4.61M20
<0.0001%
GILLIS STEVENdirector
3436456
94.0906%
$4.57M20
<0.0001%
ROCKLAGE SCOTT Mdirector
1192154
32.6413%
$1.59M10
Iwicki Mark Tdirector
307000
8.4057%
$408,310.0010
<0.0001%
Maki Daviddirector
218194
5.9742%
$290,198.0210
Sherman Matthew Ldirector
20000
0.5476%
$26,600.0010
<0.0001%

Historical Insider Profitability vs. Competitors

$6,974,678
45
-14.98%
$4.63M
$29,645,465
28
8.09%
$6.48M
$633,070
27
-5.89%
$2.04M
$63,749,694
24
-12.24%
$6.4M
$287,718
15
-41.45%
$5.68M

PULM Institutional Investors: Active Positions

Increased Positions4+19.05%21,923+6.34%
Decreased Positions8-38.1%11,012-3.18%
New Positions3New20,591New
Sold Out Positions2Sold Out132Sold Out
Total Postitions17-19.05%356,674+3.16%

PULM Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Renaissance Technologies Llc$259.002.86%114,390+3,570+3.22%2025-09-30
Sbi Securities Co., Ltd.$134.001.48%59,342-1,223-2.02%2025-09-30
Blackrock, Inc.$125.001.38%55,33500%2025-09-30
Vanguard Group Inc$112.001.24%49,409+2,400+5.11%2025-09-30
Geode Capital Management, Llc$93.001.02%40,944-140-0.34%2025-09-30
State Street Corp$32.000.35%13,94500%2025-09-30
Dimensional Fund Advisors Lp$24.000.27%10,780+10,780New2025-09-30
Tower Research Capital Llc (Trc)$3.000.04%1,436+1,028+251.96%2025-09-30
Ubs Group Ag$0<0.01%129-5,334-97.64%2025-09-30
Bank Of America Corp /De/$0<0.01%33-3-8.33%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

No data is available at this moment.
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.